A phase 1 trial of oral parathyroid hormone in healthy postmenopausal women.

Trial Profile

A phase 1 trial of oral parathyroid hormone in healthy postmenopausal women.

Completed
Phase of Trial: Phase I

Latest Information Update: 17 Mar 2009

At a glance

  • Drugs Parathyroid hormone (Primary)
  • Indications Postmenopausal osteoporosis
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Unigene Laboratories
  • Most Recent Events

    • 17 Mar 2009 Status changed from recruiting to completed, according to a Unigene media release.
    • 17 Mar 2009 Results have been reported in a Unigene media release.
    • 15 Oct 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top